Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Study identifier:D133HR00023

ClinicalTrials.gov identifier:NCT05945108

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER: Multicenter Retrospective Study (Real World Evidence – RWE)

Medical condition

Urothelial carcinoma

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

400

Study type

Observational

Age

18 Years - 100 Years

Date

Study Start Date: 10 Jul 2023
Primary Completion Date: 18 Apr 2024
Study Completion Date: 18 Apr 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

Hospital Israelita Albert Einstein

Inclusion and exclusion criteria